Equity Overview
Price & Market Data
Price: $0.0322
Daily Change: -$0.0₃65 / 2.02%
Daily Range: $0.0305 - $0.036
Market Cap: $678,451
Daily Volume: 419,584
Performance Metrics
1 Week: -14.49%
1 Month: -5.72%
3 Months: -44.57%
6 Months: -99.23%
1 Year: -99.99%
YTD: -54.72%
Details
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies and solid tumors. The company was incorporated in 2021 and is based in South San Francisco, California.